J&J Announces $23.31B Q2 Revenue. Forecasts $2.5B from 2021 Vaccine Sales
(Johnson & Johnson) Vaccine maker Johnson & Johnson expects $2.5 billion sales in its Covid-19 vaccine amidst doubts of its effectiveness against the delta variant. The company reported $23.31 billion in…